Carotech, the largest and only GMP-certified palm tocotrienol complex producer, is pleased to announce that a webinar, presented by Prof. Chandan Sen will be held on December 6th, 11am, EST. The webinar is now open for registration.
Prof. Chandan Sen is a Professor and Vice Chair of Research of Surgery at the Ohio State University Medical Center. He is the author of the most cited work in tocotrienol, in his research on tocotrienols and neuroprotection, since 2000. With over 250 publications under his name, Prof. Sen is also cited over 900 times a year in the literature. He is the Editor-in-Chief of the #1 rated journal in redox biology - Antioxidants & Redox Signaling (impact factor 8.209).
Prof. Sen was the first researcher to study tocotrienols and neuroprotection and has spent more than a decade studying tocotrienols’ potent neuroprotection properties against stroke-induced injuries. He receives research funding from the NIH (National Institute of Neurological Disorders and Stroke) and uses Tocomin® and Tocomin SupraBio® full spectrum palm tocotrienol complex in his studies.
Prof. Sen’s webinar topic is entitled “Natural Vitamin E Tocotrienol In Neuroprotection And Against Stroke”.
The Malaysian Palm Oil Council (MPOC) is the sponsor of this webinar session, which is a part of the palm fruit bioactives educational series launched since 2010.
“As a continuous effort to provide research updates and education about the beneficial effects of Tocomin® and Tocomin SupraBio® in preventing stroke-related neurodegeneration, Prof. Chandan Sen will present a detailed and highly informative webinar on December 6th at 11am Eastern Standard Time. Everyone - from consumer, researchers to members of the nutraceutical industry, must grab this opportunity to register (free registration) for this webinar in order to learn first-hand how Tocomin SupraBio® provides unique protection against stroke-related neuro injuries,”says Mr. WH Leong, Vice President, Carotech Inc.
Do not miss out on this highly informative webinar session. Register now at: